Combined immunoradiotherapy induces long-term remission of CNS relapse of peripheral, diffuse, large-cell lymphoma after allogeneic stem cell transplantation: Case study

Neuro-Oncology

Volumn 7, Issue 4, 2005, Pages 508-510

  Lotze, Christian ^a   Schüler, Frank ^a   Krüger, William H ^a   Hirt, Carsten ^a   Kirsch, Michael ^a   Vogelgesang, Silke ^a   Schmidt, Christian A ^a   Dölken, Gottfried ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Allogeneic stem cell transplantation; Anti CD20 antibodies; Graft versus lymphoma effect; Non Hodgkin's lymphoma

Indexed keywords

ANTIINFECTIVE AGENT; CD20 ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; FLUDARABINE; METHOTREXATE; PREDNISONE; RITUXIMAB; TREOSULFAN; VINCRISTINE;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BRAIN HEMORRHAGE; BRAIN RADIATION; CANCER RELAPSE; CANCER STAGING; CASE REPORT; CASE STUDY; CENTRAL NERVOUS SYSTEM TUMOR; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LARGE CELL LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; RADIATION DOSE; RADIOIMMUNOTHERAPY; SEIZURE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; TUMOR REGRESSION;

ADULT; ANTIBODIES; ANTIGENS, CD20; BRAIN NEOPLASMS; GRAFT VS LEUKEMIA EFFECT; HUMANS; LYMPHOMA, LARGE-CELL; MALE; NEOPLASM RECURRENCE, LOCAL; STEM CELL TRANSPLANTATION;

EID: 27644567898     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1152851705000256     Document Type: Article

References (8)

1. Casper, J., Knauf, W., Kiefer, T., Wolff, D., Steiner, B., Hammer, U., Wegener, R., Kleine, H.D., Wilhelm, S., Knopp, A., Hartung, G., Dolken, G., and Freund, M. (2004) Treosulfan and fludarabine: A new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. Blood 103, 725-731.
2. Classen, C.F., Debatin, K.M., Friedrich, W., and Schulz, A.S. (2003) Long-term remission of APL with a second allogeneic BMT after CNS relapse following HLA-identical allogeneic BMT. Bone Marrow Transplant. 32, 843-846.
3. Curtis, R.E., Travis, L.B., Rowlings, P.A., Socie, G., Kingma, D.W., Banks, P.M., Jaffe, E.S., Sale, G.E., Horowitz, M.M., Witherspoon, R.P., Shriner, D.A., Weisdorf, D.J., Kolb, H.J., Sullivan, K.M., Sobocinski, K.A., Gale, R.P., Hoover, R.N., Fraumeni, J.F., Jr., and Deeg, H.J. (1999) Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study. Blood 94, 2208-2216.
4. Dolken, G. (2001) Detection of minimal residual disease. Adv. Cancer Res. 82, 133-185.
5. Hibi, S., Tsunamoto, K., Todo, S., Sawada, T., Ueda, Y., Taniwaki, M., Naya, M., Hojo, M., and Imashuku, S. (1997) Chimerism analysis on mononuclear cells in the CSF after allogeneic bone marrow transplantation. Bone Marrow Transplant. 20, 503-506.
6. Kolb, H.J., Mittermuller, J., Clemm, C., Holler, E., Ledderose, G., Brehm, G., Heim, M., and Wilmanns, W. (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76, 2462-2465.
7. van Besien, K., Ha, C.S., Murphy, S., McLaughlin, P., Rodriguez, A., Amin, K., Forman, A., Romaguera, J., Hagemeister, F., Younes, A., Bachier, C., Sarris, A., Sobocinski, K.S., Cox, J.D., and Cabanillas, F. (1998) Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood 91, 1178-1184.
8. Varadi, G., Or, R., Kapelushnik, J., Naparstek, E., Nagler, A., Brautbar, C., Amar, A., Kirschbaum, M., Samuel, S., Slavin, S., and Siegal, T. (1999) Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma. Leuk. Lymphoma 34, 185-190.